Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Urologic Neoplasms × VMBP protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Neoplasms 1 Urologic Neoplasms 1 Kidney Neoplasms 1 Kidney Diseases 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma 1

Interventions

tislelizumab 1 pembrolizumab 1 enfortumab vedotin 1 cabozantinib 1 VMBP protocol 1 Nivolumab 1 Neoadjuvant Therapy 1 Gemcitabine 1 Docetaxel 1 Cisplatin 1 Carboplatin 1 Administration, Intravesical 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04300140 2023-10-30

Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Aravive, Inc.

Phase 1/2 Terminated

Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡